Scarica l'app Stockscreener
21.88
3.31%
-0.75
Dopo l'orario di chiusura:
21.88
Precedente Chiudi:
$22.63
Aprire:
$22.45
Volume 24 ore:
674.23K
Relative Volume:
0.41
Capitalizzazione di mercato:
$1.40B
Reddito:
-
Utile/perdita netta:
$-107.85M
Rapporto P/E:
-9.9005
EPS:
-2.21
Flusso di cassa netto:
$-106.82M
1 W Prestazione:
-7.91%
1M Prestazione:
-3.10%
6M Prestazione:
-35.50%
1 anno Prestazione:
-37.93%
Intervallo 1D:
$21.86
$22.57
Intervallo di 1 settimana:
$21.86
$24.03
Portata 52W:
$18.53
$51.61
Vera Therapeutics Inc Stock (VERA) Company Profile
Nome
Vera Therapeutics Inc
Settore
Industria
Telefono
650-770-0077
Indirizzo
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Confronta VERA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
21.88 | 1.44B | 0 | -107.85M | -106.82M | -2.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-05 | Ripresa | H.C. Wainwright | Buy |
| 2025-02-04 | Iniziato | Wolfe Research | Outperform |
| 2025-01-28 | Iniziato | Goldman | Buy |
| 2024-11-21 | Iniziato | Wells Fargo | Overweight |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-01-25 | Iniziato | Oppenheimer | Outperform |
| 2024-01-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-12-18 | Iniziato | Raymond James | Outperform |
| 2023-11-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-08-16 | Iniziato | Guggenheim | Buy |
| 2023-01-04 | Downgrade | Jefferies | Buy → Hold |
| 2023-01-04 | Downgrade | Wedbush | Outperform → Neutral |
| 2022-07-12 | Iniziato | JP Morgan | Overweight |
| 2022-05-02 | Iniziato | H.C. Wainwright | Buy |
| 2022-04-19 | Iniziato | Wedbush | Outperform |
Mostra tutto
Vera Therapeutics Inc Borsa (VERA) Ultime notizie
What analysts say about Vera Therapeutics Inc. stockLightning-fast capital gains - Autocar Professional
Does Vera Therapeutics Inc. stock pay reliable dividendsTremendous portfolio expansion - jammulinksnews.com
What drives Vera Therapeutics Inc. stock priceFree Trading Strategy Suggestions - Autocar Professional
Vera Therapeutics Inc. Stock Analysis and ForecastBreakthrough capital growth - jammulinksnews.com
Is Vera Therapeutics Inc. a good long term investmentBreakthrough profit margins - jammulinksnews.com
Polycythemia Vera Pipeline 2025: Latest FDA Approvals, - openPR.com
Fund Remains in Vera Therapeutics Short-Swing Trading Lawsuit - Bloomberg Law News
Vera Therapeutics Reports Positive Phase 3 ORIGIN Trial Results for Atacicept in IgA Nephropathy - MSN
how vera therapeutics inc. stock performs during market volatilityFree Deep Market Trend Analysis - Newser
How Vera Therapeutics Inc. stock performs during market volatilityReal Chart Play - Newser
What makes Vera Therapeutics Inc. stock price move sharplyFree Stock Market Forums - Newser
Why Vera Therapeutics Inc. stock attracts strong analyst attentionStable Growth Stock Picks - Newser
Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Vera Therapeutics announces refinancing of Oxford debt facility with access to up to $500M in term loans - MSN
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Vera Therapeutics Expands Team with 200K+ Shares in Stock Options and RSUs for New Hires - Stock Titan
Polycythemia Vera Clinical Trials 2025: EMA, PDMA, FDA - openPR.com
How to Take Advantage of moves in (VERA) - news.stocktradersdaily.com
10 Best High Short Interest Stocks With Huge Upside Potential - Insider Monkey
Vera Therapeutics (VERA): Insider Buying and Clinical Breakthroughs Signal a Golden Opportunity - AInvest
Is Vera Therapeutics (NASDAQ:VERA) Weighed On By Its Debt Load? - simplywall.st
Hedge Fund and Insider Trading News: Bill Ackman, Steve Cohen, Ray Dalio, Philippe Laffont, David Tepper, Whale Rock Capital Management, Vera Therapeutics Inc (VERA), Pinterest Inc (PINS), and More - Insider Monkey
Vera Therapeutics Inc Azioni (VERA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):